The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1270 articles
A new generation of weight loss medications is emerging, promising to be even more effective for human health. These include pills, more powerful injectables, and novel compounds that may have reduced side effects or require only monthly administration.
A newly discovered mechanism explains limited nerve regeneration in diabetes, offering a promising therapeutic approach. Research demonstrates that targeting a specific signaling pathway can significantly improve nerve fiber regrowth in preclinical models.
The U.S. government has successfully negotiated a 71% discount on Novo Nordisk's popular drugs Ozempic and Wegovy for Medicare beneficiaries. These price reductions, resulting from recent legislation, will be implemented in 2027, potentially saving millions of dollars.
Indian drugmakers are modifying their pricing strategies for weight-loss injections after Novo Nordisk decreased the price of Wegovy. Generic companies are now reassessing their launch prices due to this shift. Competition is anticipated to lower prices in the GLP-1 market.
New research indicates a connection between body composition and brain aging. The study suggests that individuals with more muscle mass and less hidden belly fat tend to have younger-appearing brains, as observed through MRI scans.
The federal government has negotiated lower prices for 15 widely used medications covered by Medicare, potentially cutting spending by 44%. While Medicare enrollees are protected by a cap on drug costs, the new prices could save millions enrolled in the Part D pharmaceutical plan a total of about $685 million.
Results from a recent trial indicate that semaglutide, typically used for obesity, did not slow the progression of Alzheimer's disease. While the drug improved Alzheimer's-related biomarkers, this did not translate to a delay in the disease's advancement. Researchers emphasize the need for multi-faceted approaches to tackle Alzheimer's.
Lizzo has voiced her concerns regarding the current weight-loss culture and its impact on plus-size women. She believes that the rise of weight-loss drugs like Ozempic is leading to the 'erasure' of plus-size representation.
China's pharmaceutical industry is rapidly ascending on the global stage, fueled by innovation and strategic alliances with Western companies. This rise presents both opportunities and challenges as China aims to become a major player in drug discovery and development.
